Rheumatology Therapeutics Market Size is Anticipated to Surpass Revenue of USD 65.1 Billion by 2034 at a Grow CAGR of 2.6% | Transparency Market Research Inc.
14. August 2024 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc.-, Aug. 14, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global rheumatology...
AI Therapeutics Announces Initiation of a Phase 2 Clinical Trial of LAM-001 for Treatment of Pulmonary Arterial Hypertension (PAH)
31. August 2023 10:38 ET
|
AI Therapeutics, Inc.
GUILFORD, Conn., Aug. 31, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the initiation...
Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology
14. November 2017 07:00 ET
|
Neuronascent, Inc.
CLARKSVILLE, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Neuronascent, Inc. (www.neuronascent.com), a biopharmaceutical company focused on oral therapeutics to promote neuron regeneration, today...